Maximizing neuroprotection: Where do we stand?

Therapeutics and Clinical Risk Management

Volumn 8, Issue , 2012, Pages 185-194

  Kuffler, Damien P ^a  

^a UNIVERSITY OF PUERTO RICO   (Puerto Rico)

Author keywords

Adenosine; Alkalinization; Glucocorticoids; Hypothermia

Indexed keywords

ADENOSINE; ADENOSINE A2A RECEPTOR AGONIST; ADENOSINE RECEPTOR STIMULATING AGENT; ANTIOXIDANT; CALCIUM ION; ERYTHROPOIETIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROPEPTIDE; NEUROTROPHIC FACTOR;

ACIDOSIS; ALKALINIZATION; BRAIN ISCHEMIA; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CELL LINE; EXCITOTOXICITY; HEAD INJURY; HUMAN; HYPERTHERMIA; INDUCED HYPOTHERMIA; NERVE CELL PLASTICITY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; REVIEW; STEM CELL;

EID: 84866918954     PISSN: 11766336     EISSN: 1178203X     Source Type: Journal    
DOI: 10.2147/TCRM.S16196     Document Type: Review

References (110)

1. Schwab ME, Bartholdi D. Degeneration and regeneration of axons in the lesioned spinal cord. Physiol Rev. 1996;76(2):319-370.
2. Choi DW. Cerebral hypoxia: some new approaches and unanswered questions. J Neurosci. 1990;10(8):2493-2501.
3. Schnell L, Fearn S, Klassen H, Schwab ME, Perry VH. Acute inflammatory responses to mechanical lesions in the CNS: differences between brain and spinal cord. Eur J Neurosci. 1999;11(10):3648-3658.
4. Cuzzocrea S, McDonald MC, Mazzon E, et al. Effects of tempol, a membrane-permeable radical scavenger, in a gerbil model of brain injury. Brain Research. 2000;875(1-2):96-106.
5. Flamm ES, Demopoulos HB, Seligman ML, Poser RG, Ransohoff J. Free radicals in cerebral ischemia. Stroke. 1978;9(5):445-447.
6. Reyes O, Sosa I, Kuffler DP. Neuroprotection of adult human neurons against ischemia by hypothermia and alkalinization. P R Health Sci J. 2006;25(1):43-50.
7. Amorim P, Cottrell JE, Kass IS. Effect of small changes in temperature on CA1 pyramidal cells from rat hippocampal slices during hypoxia: implications about the mechanism of hypothermic protection against neuronal damage. Brain Res. 1999;844(1-2):143-149.
8. Sucher NJ, Lipton SA, Dreyer EB. Molecular basis of glutamate toxicity in retinal ganglion cells. Vision Res. 1997;37(24):3483-3493.
9. Frandsen A, Schousboe A. Dantrolene prevents glutamate cytotoxicity and Ca2+ release from intracellular stores in cultured cerebral cortical neurons. J Neurochem. 1991;56(3):1075-1078.
10. Cebers G, Cebere A, Liljequist S. Metabolic inhibition potentiates AMPA-induced Ca2+ fluxes and neurotoxicity in rat cerebellar granule cells. Brain Res. 1998;779(1-2):194-204.
11. Leist M, Nicotera P. Calcium and neuronal death. Rev Physiol Biochem Pharmacol. 1998;132:79-125.
12. Wang C, Nguyen HN, Maguire JL, Perry DC. Role of intracellular calcium stores in cell death from oxygen-glucose deprivation in a neuronal cell line. J Cereb Blood Flow Metab. 2002;22(2):206-214.
13. Demierre N, Wyler D, Zollinger U, Bolliger S, Plattner T. Elevated body core temperature in medico-legal investigation of violent death. Am J Forensic Med Pathol. 2009;30(2):155-158.
14. Bahniwal M, Villanueva EB, Klegeris A. Moderate increase in temperature may exacerbate neuroinflammatory processes in the brain: human cell culture studies. J Neuroimmunol. 2011;233(1-2):65-72.
15. Kiyatkin EA. Brain temperature homeostasis: physiological fluctuations and pathological shifts. Front Biosci. 2010;15:73-92.
16. Dusart I, Schwab ME. Secondary cell death and the inflammatory reaction after dorsal hemisection of the rat spinal cord. Eur J Neurosci. 1994;6(5):712-724.
17. Schnell L, Schneider R, Berman MA, Perry VH, Schwab ME. Lymphocyte recruitment following spinal cord injury in mice is altered by prior viral exposure. Eur J Neurosci. 1997;9(5):1000-1007.
18. Blight AR. Macrophages and inflammatory damage in spinal cord injury. J Neurotrauma. 1992;9 Suppl 1:S83-S91.
19. Liu T, Clark RK, McDonnell PC, et al. Tumor necrosis factor-alpha expression in ischemic neurons. Stroke. 1994;25(7):1481-1488.
20. Kaushal V, Schlichter LC. Mechanisms of microglia-mediated neurotoxicity in a new model of the stroke penumbra. J Neurosci. 2008;28(9):2221-2230.
21. Bartholdi D, Schwab ME. Expression of pro-inflammatory cytokine and chemokine mRNA upon experimental spinal cord injury in mouse: an in situ hybridization study. Eur J Neurosci. 1997;9(7):1422-1438.
22. Fitch MT, Silver J. CNS injury, glial scars, and inflammation: inhibitory extracellular matrices and regeneration failure. Exp Neurol. 2008;209(2):294-301.
23. Pearse D, Jarnagin K. Abating progressive tissue injury and preserving function after CNS trauma: the role of inflammation modulatory therapies. Curr Opin Investig Drugs. 2010;11(11):1207-1210.
24. Zhang Q, Huang C, Tang T, Shi Q, Yang H. Comparative neuroprotective effects of methylprednisolone and rosiglitazone, a peroxisome proliferator- activated receptor-gamma following spinal cord injury. Neurosciences (Riyadh). 2011;16(1):46-52.
25. Chen T-Y, Tai S-H, Lee E-J, et al. Cinnamophilin offers prolonged neuroprotection against gray and white matter damage and improves functional and electrophysiological outcomes after transient focal cerebral ischemia. Crit Care Med. 2011;39:1130-1137.
26. Wang MJ, Lin SZ, Kuo JS, Huang HY, Tzeng SF. Urocortin modulates inflammatory response and neurotoxicity induced by microglial activation. J Immunol. 2007;179:6204-6214.
27. Choi DW. Methods for antagonizing glutamate neurotoxicity. Cerebrovasc Brain Metab Rev. 1990;2(2):105-147.
28. Zipfel GJ, Babcock DJ, Lee JM, Choi DW. Neuronal apoptosis after CNS injury: the roles of glutamate and calcium. J Neurotrauma. 2000;17(10):857-869.
29. Garthwaite J, Garthwaite G. Mechanisms of excitatory amino acid neurotoxicity in rat brain slices. Adv Exp Med Biol. 1990;268:505-518.
30. Lee CJ, Engelman HS, MacDermott AB. Activation of kainate receptors on rat sensory neurons evokes action potential firing and may modulate transmitter release. Ann N Y Acad Sci. 1999;868:546-549.
31. Choi DW. Possible mechanisms limiting N-methyl-D-aspartate receptor overactivation and the therapeutic efficacy of N-methyl-D-aspartate antagonists. Stroke. 1990;21(11 Suppl):III20-III22.
32. Ding D, Moskowitz SI, Li R, et al. Acidosis induces necrosis and apoptosis of cultured hippocampal neurons. Exp Neurol. 2000;162(1):1-12.
33. Benveniste H. The excitotoxin hypothesis in relation to cerebral ischemia. Cerebrovasc Brain Metab Rev. 1991;3(3):213-245.
34. Choi DW, Koh JY, Peters S. Pharmacology of glutamate neurotoxicity in cortical cell culture: attenuation by NMDA antagonists. J Neurosci. 1988;8(1):185-196.
35. Coyle JT, Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science. 1993;262(5134):689-695.
36. Bhattacharya R, Lakshmana Rao PV. Pharmacological interventions of cyanide-induced cytotoxicity and DNA damage in isolated rat thymocytes and their protective efficacy in vivo. Toxicol Lett. 2001;119(1):59-70.
37. Schafer FQ, Buettner GR. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med. 2001;30(11):1191-1212.
38. Abdollahi H, Harris LJ, Zhang P, et al. The role of hypoxia in stem cell differentiation and therapeutics. J Surg Res. 2011;165(1): 112-117.
39. Li L, Prabhakaran K, Shou Y, Borowitz JL, Isom GE. Oxidative stress and cyclooxygenase-2 induction mediate cyanide-induced apoptosis of cortical cells. Toxicol Appl Pharmacol. 2002;185(1): 55-63.
40. Lennon SV, Martin SJ, Cotter TG. Dose-dependent induction of apoptosis in human tumour cell lines by widely diverging stimuli. Cell Prolif. 1991;24(2):203-214.
41. Reynolds IJ, Hastings TG. Glutamate induces the production of reactive oxygen species in cultured forebrain neurons following NMDA receptor activation. J Neurosci. 1995;15(5 Pt 1): 3318-3327.
42. Monyer H, Seeburg PH. Constituents involved in glutamate receptor signaling. Hippocampus. 1993;3:125-129.
43. Kanthasamy AG, Maduh EU, Peoples RW, Borowitz JL, Isom GE. Calcium mediation of cyanide-induced catecholamine release: implications for neurotoxicity. Toxicol Appl Pharmacol. 1991;110(2):275-282.
44. Hirata H, Machado LS, Okuno CS, Brasolin A, Lopes GS, Smaili SS. Apoptotic effect of ethanol is potentiated by caffeine-induced calcium release in rat astrocytes. Neurosci Lett. 2006;393(2-3): 136-140.
45. Dubinsky JM, Rothman SM. Intracellular calcium concentrations during "chemical hypoxia" and excitotoxic neuronal injury. J Neurosci. 1991;11(8):2545-2551.
46. Choi DW. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1988;1(8):623-634.
47. Rajdev S, Reynolds IJ. Glutamate-induced intracellular calcium changes and neurotoxicity in cortical neurons in vitro: effect of chemical ischemia. Neuroscience. 1994;62(3):667-679.
48. Debillon T, Daoud P, Durand P, et al. Whole-body cooling after perinatal asphyxia: a pilot study in term neonates. Dev Med Child Neurol. 2003;45(1):17-23.
49. Parrino PE, Kron IL, Ross SD, et al. Spinal cord protection during aortic cross-clamping using retrograde venous perfusion. Ann Thorac Surg. 1999;67(6):1589-1594; discussion 1594-1585.
50. Mori K, Maeda T, Shiraishi Y, Kawai Y. Effects of hypothermia on blood flow and neural activity in rabbit spinal cord during postischemic reperfusion. Jpn J Physiol. 2001;51(1):71-79.
51. Mori K, Maeda M, Miyazaki M, Iwase H. Effects of mild (33 degrees C) and moderate (29 degrees C) hypothermia on cerebral blood flow and metabolism, lactate, and extracellular glutamate in experimental head injury. Neurol Res. 1998;20(8):719-726.
52. Sosa IJ, Reyes O, Inserni J, Kuffler DP. Isolation and long-term survival of adult human sensory neurons in vitro. Neurosurgery. 1998;42(3):681- 685; discussion 685-686.
53. Nishi H, Nakatsuka T, Takeda D, et al. Hypothermia suppresses excitatory synaptic transmission and neuronal death induced by experimental ischemia in spinal ventral horn neurons. Spine (Phila Pa 1976). 2007;32(25):E741-E747.
54. Yenari MA. Heat shock proteins and neuroprotection. Adv Exp Med Biol. 2002;513:281-299.
55. Musleh W, Alvarez S, Baudry M, Alkana RL. Effects of ethanol and temperature on NMDA receptor function in different mouse genotypes. Alcohol Clin Exp Res. 1996;20(7):1299-1304.
56. Lucas JH, Emery DG, Wang G, Rosenberg-Schaffer LJ, Jordan RS, Gross GW. In vitro investigations of the effects of nonfreezing low temperatures on lesioned and uninjured mammalian spinal neurons. J Neurotrauma. 1994;11(1):35-61.
57. Kuffler DP. Combinatorial techniques for enhancing neuroprotection: hypothermia and alkalinization. Ann N Y Acad Sci. 2010;1199: 164-174.
58. Zitta K, Meybohm P, Bein B, et al. Hypoxia-induced cell damage is reduced by mild hypothermia and postconditioning with catalase in- vitro: application of an enzyme based oxygen deficiency system. Eur J Pharmacol. 2010;628(1-3):11-18.
59. Gupta AK, Al-Rawi PG, Hutchinson PJ, Kirkpatrick PJ. Effect of hypothermia on brain tissue oxygenation in patients with severe head injury. Br J Anaesth. 2002;88(2):188-192.
60. Robertson CL, Scafidi S, McKenna MC, Fiskum G. Mitochondrial mechanisms of cell death and neuroprotection in pediatric ischemic and traumatic brain injury. Exp Neurol. 2009;218(2):371-380.
61. Erecinska M, Thoresen M, Silver IA. Effects of hypothermia on energy metabolism in Mammalian central nervous system. J Cereb Blood Flow Metab. 2003;23(5):513-530.
62. Slikker W 3rd, Desai VG, Duhart H, Feuers R, Imam SZ. Hypothermia enhances bcl-2 expression and protects against oxidative stress-induced cell death in Chinese hamster ovary cells. Free Radic Biol Med. 2001;31(3):405-411.
63. Kuffler DP. Neuroprotection by hypothermia plus alkalinization of dorsal root ganglia neurons through ischemia. Ann N Y Acad Sci. 2010;1199:158-163.
64. Alam HB, Hashmi S, Finkelstein RA, et al. Alterations in gene expression after induction of profound hypothermia for the treatment of lethal hemorrhage. J Trauma. 2010;68(5):1084-1098.
65. Skaper SD, Facci L, Kee WJ, Strijbos PJ. Potentiation by histamine of synaptically mediated excitotoxicity in cultured hippocampal neurones: a possible role for mast cells. J Neurochem. 2001;76(1):47-55.
66. Ishikawa T, Marsala M. Hypothermia prevents biphasic glutamate release and corresponding neuronal degeneration after transient spinal cord ischemia in the rat. Cell Mol Neurobiol. 1999;19(2):199-208.
67. Dietrich WD, Busto R, Alonso O, Globus MY, Ginsberg MD. Intraischemic but not postischemic brain hypothermia protects chronically following global forebrain ischemia in rats. J Cereb Blood Flow Metab. 1993;13(4):541-549.
68. Jorgensen NK, Petersen SF, Damgaard I, Schousboe A, Hoffmann EK. Increases in [Ca2+]i and changes in intracellular pH during chemical anoxia in mouse neocortical neurons in primary culture. J Neurosci Res. 1999;56(4):358-370.
69. Reyes O, Sosa I, Kuffler DP. Neuroprotection of adult human neurons against ischemia by hypothermia and alkalinization. P R Health Sci J. 2006;25(1):43-50.
70. Henrich M, Buckler KJ. Effects of anoxia and aglycemia on cytosolic calcium regulation in rat sensory neurons. J Neurophysiol. 2008;100(1):456-473.
71. Chesler M. pH regulation in the vertebrate central nervous system: microelectrode studies in the brain stem of the lamprey. Can J Physiol Pharmacol. 1987;65(5):986-993.
72. Goss SL, Lemons KA, Kerstetter JE, Bogner RH. Determination of calcium salt solubility with changes in pH and P(CO(2)), simulating varying gastrointestinal environments. J Pharm Pharmacol. 2007;59(11):1485-1492.
73. Maduh EU, Borowitz JL, Isom GE. Cyanide-induced alteration of cytosolic pH: involvement of cellular hydrogen ion handling processes. Toxicol Appl Pharmacol. 1990;106(2):201-208.
74. Yang CW, Borowitz JL, Gunasekar PG, Isom GE. Cyanide-stimulated inositol 1,4,5-trisphosphate formation: an intracellular neurotoxic signaling cascade. J Biochem Toxicol. 1996;11(5):251-256.
75. Gemignani A, Paudice P, Longordo F, Raiteri M. External pH changes affect NMDA-evoked and spontaneous release of cholecystokinin, somatostatin and noradrenaline from rat cerebrocortical nerve endings. Neurochem Int. 2004;45(5):677-685.
76. Chen YH, Wu ML, Fu WM. Regulation of presynaptic NMDA responses by external and intracellular pH changes at developing neuromuscular synapses. J Neurosci. 1998;18(8):2982-2990.
77. Vincent AM, TenBroeke M, Maiese K. Neuronal intracellular pH directly mediates nitric oxide-induced programmed cell death. J Neurobiol. 1999;40(2):171-184.
78. Schubert P, Ogata T, Marchini C, Ferroni S, Rudolphi K. Protective mechanisms of adenosine in neurons and glial cells. Ann N Y Acad Sci. 1997;825:1-10.
79. Cassada DC, Tribble CG, Long SM, et al. Adenosine A2A agonist reduces paralysis after spinal cord ischemia: correlation with A2A receptor expression on motor neurons. Ann Thorac Surg. 2002;74(3):846- 849; discussion 849-850.
80. Ross SD, Kern JA, Gangemi JJ, et al. Hypothermic retrograde venous perfusion with adenosine cools the spinal cord and reduces the risk of paraplegia after thoracic aortic clamping. J Thorac Cardiovasc Surg. 2000;119(3):588-595.
81. Hu HZ, Li ZW. Modulation by adenosine of GABA-activated current in rat dorsal root ganglion neurons. J Physiol. 1997;501(Pt 1):67-75.
82. Cruz O, Kuffler DP. Neuroprotection of adult rat dorsal root ganglion neurons by combined hypothermia and alkalinization against prolonged ischemia. Neuroscience. 2005;132(1):115-122.
83. Reece TB, Tribble CG, Okonkwo DO, et al. Early adenosine receptor activation ameliorates spinal cord reperfusion injury. J Cardiovasc Med (Hagerstown). 2008;9(4):363-367.
84. Wardas J. Neuroprotective role of adenosine in the CNS. Pol J Pharmacol. 2002;54(4):313-326.
85. Stone TW. Purines and neuroprotection. Adv Exp Med Biol. 2002;513:249-280.
86. Calabresi P, Picconi B, Saulle E, Centonze D, Hainsworth AH, Bernardi G. Is pharmacological neuroprotection dependent on reduced glutamate release? Stroke. 2000;31(3):766-772; discussion 773.
87. Stone TW, Ceruti S, Abbracchio MP. Adenosine receptors and neurological disease: neuroprotection and neurodegeneration. Handb Exp Pharmacol. 2009;193:535-587.
88. Yang JP, Liu HJ, Yang H, Feng PY. Therapeutic time window for the neuroprotective effects of NGF when administered after focal cerebral ischemia. Neurol Sci. 2011;32(3):433-441.
89. Mao QQ, Zhong XM, Qiu FM, Li ZY, Huang Z. Protective effects of paeoniflorin against corticosterone-induced neurotoxicity in PC12 cells. Phytother Res. 2011. Epub Dec 1.
90. De Santi L, Polimeni G, Cuzzocrea S, et al. Neuroinflammation and neuroprotection: an update on (future) neurotrophin-related strategies in multiple sclerosis treatment. Curr Med Chem. 2011;18(12):1775-1784.
91. Skaper SD. Peptide mimetics of neurotrophins and their receptors. Curr Pharm Des. 2011;17(25):2704-2718.
92. Chiu CT, Wen LL, Pao HP, Wang JY. Cortistatin is induced in brain tissue and exerts neuroprotection in a rat model of bacterial meningoencephalitis. J Infect Dis. 2011;204(10):1563-1572.
93. Decressac M, Pain S, Chabeauti PY, et al. Neuroprotection by neuropeptide Y in cell and animal models of Parkinson's disease. Neurobiol Aging. 2011. Epub Aug 2.
94. Cook DR, Gleichman AJ, Cross SA, et al. NMDA receptor modulation by the neuropeptide apelin: implications for excitotoxic injury. J Neurochem. 2011;118(6):1113-1123.
95. Elliott-Hunt CR, Holmes FE, Hartley DM, Perez S, Mufson EJ, Wynick D. Endogenous galanin protects mouse hippocampal neurons against amyloid toxicity in vitro via activation of galanin receptor-2. J Alzheimers Dis. 2011;25(3):455-462.
96. Haas C, Neuhuber B, Yamagami T, Rao M, Fischer I. Phenotypic analysis of astrocytes derived from glial restricted precursors and their impact on axon regeneration. Exp Neurol. 2011;233(2): 717-732.
97. Kogel D, Deller T, Behl C. Roles of amyloid precursor protein family members in neuroprotection, stress signaling and aging. Exp Brain Res. 2011. Epub Nov 16.
98. Kohman RA, Deyoung EK, Bhattacharya TK, Peterson LN, Rhodes JS. Wheel running attenuates microglia proliferation and increases expression of a proneurogenic phenotype in the hippocampus of aged mice. Brain Behav Immun. 2011. Epub Oct 25.
99. Correia SC, Cardoso S, Santos RX, et al. New insights into the mechanisms of mitochondrial preconditioning-triggered neuroprotection. Curr Pharm Des. 2011;17(31):3381-3389.
100. Onishi A, Miyamae M, Kaneda K, Kotani J, Figueredo VM. Direct evidence for inhibition of mitochondrial permeability transition pore opening by sevoflurane preconditioning in cardiomyocytes: comparison with cyclosporine A. Eur J Pharmacol. 2012;675(1-3): 40-46.
101. Gao CJ, Niu L, Ren PC, et al. Hypoxic preconditioning attenuates global cerebral ischemic injury following asphyxial cardiac arrest through regulation of delta opioid receptor system. Neuroscience. 2011;202:352-362.
102. Yang L, Fan M, Du F, et al. The increased iron transport rate induced by hypoxic preconditioning in astrocytes. Biochim Biophys Acta. 2012. Epub Dec 16.
103. Diederich K, Schabitz WR, Minnerup J. Seeing old friends from a different angle: novel properties of hematopoietic growth factors in the healthy and diseased brain. Hippocampus. 2010. Epub Dec 6.
104. Fan X, Kavelaars A, Heijnen CJ, Groenendaal F, van Bel F. Pharmacological neuroprotection after perinatal hypoxic-ischemic brain injury. Curr Neuropharmacol. 2010;8(4):324-334.
105. Rees S, Harding R, Walker D. The biological basis of injury and neuroprotection in the fetal and neonatal brain. Int J Dev Neurosci. 2011;29(6):551-563.
106. Zaverucha-do-Valle C, Gubert F, Bargas-Rega M, et al. Bone marrow mononuclear cells increase retinal ganglion cell survival and axon regeneration in the adult rat. Cell Transplant. 2011;20(3): 391-406.
107. Wakabayashi K, Nagai A, Sheikh AM, et al. Transplantation of human mesenchymal stem cells promotes functional improvement and increased expression of neurotrophic factors in a rat focal cerebral ischemia model. J Neurosci Res. 2010;88(5):1017-1025.
108. Arien-Zakay H, Lecht S, Nagler A, Lazarovici P. Neuroprotection by human umbilical cord bloodderived progenitors in ischemic brain injuries. Arch Ital Biol. 2011;149(2):233-245.
109. Narantuya D, Nagai A, Sheikh AM, et al. Human microglia transplanted in rat focal ischemia brain induce neuroprotection and behavioral improvement. PLoS One. 2010;5(7):e11746.
110. Reece TB, Okonkwo DO, Ellman PI, et al. Comparison of systemic and retrograde delivery of adenosine A2A agonist for attenuation of spinal cord injury after thoracic aortic cross-clamping. Ann Thorac Surg. 2006;81(3):902-909.